Abstract
Genital herpes is caused by herpes simplex virus (HSV)-1 and HSV-2. It is an underdiagnosed and undertreated sexually transmitted infection characterised by latency followed by reactivation. The seroprevalence of both types of HSV varies throughout Europe, and HSV-1 is an increasing cause of genital herpes. Transmission is through skin-to-skin contact, and neonatal herpes resulting from transmission during delivery is a particularly serious problem. Diagnosis of genital herpes is not straightforward, and a clinical diagnosis alone is usually insufficient. Correct diagnosis is essential for appropriate management and reduction of transmission. Laboratory diagnosis can be by direct detection of the virus or indirect measurement of antibodies. Direct testing has traditionally been through culture of the virus, but detection of viral nucleic acids by real-time polymerase chain reaction is now considered the gold standard method. Type-specific serological testing based on glycoprotein G also has a role in asymptomatic patients or those with non-specific symptoms and in identifying serodiscordant couples, pregnant women at risk and patients co-infected with HIV and HSV-2. Having made an accurate diagnosis, effective management of genital herpes is by treatment with an oral antiviral agent and patient counselling.
Similar content being viewed by others
References
Strand A, Barton S, Alomar A et al (2002) Current treatments and perceptions of genital herpes: a European-wide view. J Eur Acad Dermatol Venereol 16:564–572
Guthrie R (1999) American Herpes Foundation Monitor 1:1
Malkin J-E (2004) Epidemiology of genital herpes simplex infection in developed countries. Herpes 11(Suppl 1):2A–23A
Beauman JG (2005) Genital herpes: a review. Am Fam Physician 72:1527–1534
Xu F, Sternberg MR, Kottiri BJ et al (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296:964–973
Looker KJ, Garnett GP (2005) A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect 81:103–107
Lafferty WE, Downey L, Celum C, Wald A (2000) Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 181:1454–1457
Löwhagen GB, Tunbäck P, Andersson K et al (2000) First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect 76:179–182
Cowan FM, Johnson AM, Ashley R et al (1994) Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 309:1325–1329
Gottlieb SL, Douglas JM Jr, Schmid DS et al (2002) Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 186:1381–1389
Cusini M, Cusan M, Parolin C et al (2000) Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Sex Transm Dis 27:292–295
Austin H, Macaluso M, Nahmias A et al (1999) Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis 26:329–334
Gibson JJ, Hornung CA, Alexander GR et al (1990) A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 162:306–312
Russell DB, Tabrizi SN, Russell JM et al (2001) Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol 22:305–313
Conde-Glez CJ, Juarez-Figueroa L, Uribe-Salas F et al (1999) Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behaviour in Mexico. Int J Epidemiol 28:571–576
Corey L, Adams HG, Brown ZA, Holmes KK (1983) Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 98:958–972
Wald A, Zeh J, Selke S et al (2000) Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342:844–850
Corey L (1994) The current trend in genital herpes: progress in prevention. Sex Transm Dis 21:538–544
Benedetti J, Corey L, Ashley R (1994) Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 121:847–854
Habif TP (1996) Clinical dermatology, 4th edn. Mosby, St Louis, pp 306–310
Corey L (1988) First-episode, recurrent, and asymptomatic herpes simplex infections. J Am Acad Dermatol 18:169–172
Langenberg AG, Corey L, Ashley RL et al (1999) A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 341:1432–1438
Koutsky LA, Stevens CE, Holmes KK et al (1992) Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med 326:1533–1539
Ashley RL, Wald A (1999) Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev 12:1–8
Markos AR (2004) Successful management of vulvar adhesions with potent topical corticosteroids: a case report. J Reprod Med 49:398–400
Lautenschlager S, Eichmann A (2001) The heterogeneous clinical spectrum of genital herpes? Dermatology 202:211–219
Uuskula A, Raukas E (2004) Atypical genital herpes: report of five cases. Scand J Infect Dis 36:37–39
Mertz GJ, Schmidt O, Jourden JL et al (1985) Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis 12:33–39
Koelle DM, Wald A (2000) Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 45(Suppl T3):1–8
Corey L, Simmons A (eds) (1997) The medical importance of genital herpes simplex virus infection. International Herpes Management Forum
Wald A, Zeh J, Selke S et al (1995) Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333:770–775
Wald A, Corey L, Cone R et al (1997) Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 99:1092–1097
Mertz GJ, Benedetti J, Ashley R et al (1992) Risk factors for the sexual transmission of genital herpes. Ann Intern Med 116:197–202
Nahmias AJ, Lee FK, Beckman-Nahmias S (1990) Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis 69(Suppl):19–36
Schacker T, Hu HL, Koelle DM et al (1998) Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons: a double-blind, placebo-controlled trial. Ann Intern Med 128:21–28
Hutto C, Arvin A, Jacobs R et al (2003) Intrauterine herpes simplex virus infections. J Pediatr 110:97–101
Brown Z, Sleke S, Zeh J et al (1997) The acquisition of herpes simplex virus during pregnancy. N Engl J Med 337:509–515
Brown ZA, Wald A, Morrow RA et al (2003) Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289:203–209
Kohl S (1997) Neonatal herpes simplex virus infection. Clin Perinatol 24:129–150
Griffiths PD, Volpi A (eds) (1997) Progress with diagnostic tests and vaccines for alpha-herpes viruses. International Herpes Management Forum
Celum CL (2004) The interaction between herpes simplex virus and human immunodeficiency virus. Herpes 11(Suppl 1):36A–45A
Filen F, Strand A, Allard A et al (2004) Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis 31:331–336
Löwhagen GB, Tunbäck P, Bergström T (2002) Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol 82:118–120
Strick LB, Wald A (2006) Diagnostics for herpes simplex virus: is PCR the new gold standard? Mol Diagn Ther 10:17–28
Mackay IM, Arden KE, Nitsche A (2002) Real-time PCR in virology. Nucleic Acids Res 30:1292–1305
Nicoll S, Brass A, Cubie HA (2001) Detection of herpes viruses in clinical samples using real-time PCR. J Virol Methods 96:25–31
Read SJ, Kurtz JB (1999) Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol 37:1352–1355
Burrows J, Nitsche A, Bayly B et al (2002) Detection and subtyping of herpes simplex virus in clinical samples by lightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol 2:12
Ramaswamy M, McDonald C, Smith M et al (2004) Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect 80:406–410
Scoular A, Gillespie G, Carman WF (2002) Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect 78:21–25
Strick L, Wald A (2004) Type-specific testing for herpes simplex virus. Expert Rev Mol Diagn 4:443–453
Page J, Taylor J, Tideman RL et al (2003) Is HSV serology useful for the management of first episode genital herpes? Sex Transm Infect 79:276–279
Morrow R, Friedrich D (2006) Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. Clin Microbiol Infect 12:463–469
Australian Herpes Management Forum (2004) The use of type-specific serology for the diagnosis of genital herpes. AHMF, Westmead NSW
Bryson Y, Dillon M, Bernstein DI et al (1993) Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 167:942–946
McClelland RS, Wand CC, Overbaugh J et al (2002) Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 16:2425–2430
Kulhanjian JA, Soroush V, Au DS et al (1992) Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 326:916–920
Zimet GD, Rosenthal SL, Fortenberry JD et al (2004) Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. Sex Transm Dis 31:665–669
Krantz I, Löwhagen G-B, Ahlberg BM, Nilstun T (2004) Ethics of screening for asymptomatic herpes virus type 2 infection. BMJ 329:618–621
International Herpes Management Forum (2000) Algorithms for managing genital herpes in primary care
Bodsworth NJ, Crooks RJ, Borelli S et al (1997) Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. Genitourin Med 73:110–116
Chosidow O, Drouault Y, Leconte-Veyriac F et al (2001) Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 144:818–824
Whitley RJ (2006) New approaches to the therapy of HSV infections. Herpes 13:53–55
Mertz GJ, Loveless M, Levin M et al (1997) Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Arch Intern Med 157:343–349
Patel R, Bodsworth NJ, Woolley P et al (1997) Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. Genitourin Med 73:105–109
Patel R, Tyring S, Strand A et al (1999) Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect 75:398–402
Romanowksi B, Marina RB, Roberts JN (2003) Patients’ preference of valacyclovir once-daily suppressive therapy versus twice-daily episodic therapy for recurrent genital herpes: a randomized study. Sex Transm Dis 30:226–231
Corey L, Wald A, Patel R et al (2004) Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350:11–20
Catotti DN, Clarke P, Catoe KE (1993) Herpes revisited: still a cause for concern. Sex Transm Dis 20:77–80
Melville J, Sniffen S, Crosby R et al (2003) Psychosocial impact of a serological diagnosis of herpes simplex virus type 2: a qualitative assessment. Sex Transm Infect 79:280–285
Patel R (2004) Supporting the patient with genital HSV infection. Herpes 11:87–92
Acknowledgment
The development of this article was supported by an educational grant from GlaxoSmithKline. Editorial assistance was provided by Synergy.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strand, A. Diagnosis of genital herpes: the role and place of HSV testing in clinical practice. Eur Clinics Obstet Gynaecol 2, 181–189 (2006). https://doi.org/10.1007/s11296-006-0057-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11296-006-0057-2